Litcius/Paper detail

End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial

Luca Guerra, Stéphane Chauvie, Federico Fallanca, Fabrizio Bergesio, Luigi Marcheselli, Rexhep Durmo, S. Peano, Antonella Franceschetto, Lavinia Monaco, Emiliano Barbieri, Marco Ladetto, Gerardo Musuraca, Patrizia Tosi, Benedetta Bianchi, Silvia Bolis, Vincenzo Pavone, Annalisa Chiarenza, Annalisa Arcari, Catello Califano, Alessia Bari, Massimo Massaia, Annarita Conconi, Pellegrino Musto, Donato Mannina, Giovanni Roti, Sara Galimberti, Guido Gini, Flavio Falcinelli, Umberto Vitolo, Sara Veronica Usai, Piero Maria Stefani, Adalberto Ibatici, Anna Marina Liberati, Elsa Pennese, Tommasina Perrone, Annibale Versari, Stefano Luminari, on behalf of Fondazione Italiana Linfomi (FIL)

2024European Journal of Nuclear Medicine and Molecular Imaging10 citationsDOIOpen Access PDF

Topics & Concepts

Follicular lymphomaMedicineProgression-free survivalOncologyLymphomaInternal medicinePositron emission tomographyOverall survivalNuclear medicineRadiologyLymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchCNS Lymphoma Diagnosis and Treatment